# Congressional stock trades in VRTX (Vertex Pharmaceuticals Inc)

Congressional stock trades in Vertex Pharmaceuticals Inc (VRTX) from House and Senate STOCK Act filings. See which members of Congress bought or sold, disclosed amounts, and filing dates.

- Industry: Pharmaceutical Preparations
- Last close: $508.34
- Price updated: Sep 19, 2026
- Total congressional trades: 10
- Politicians trading: 4
- Last traded: Aug 26, 2026
- Source: https://tryglasshouse.ai/companies/VRTX.md

## Trading History

- Page: 1 of 1
- Results: 10 of 10
- Pagination query parameter: `page`

## 1. David Taylor

- Member: Republican, House
- Transaction: Sell, $1,001 - $15,000
- Dates: traded Aug 26, 2026, disclosed Sep 5, 2026
- Market context: $547.29 at trade, $508.34 current (-7.12%)
- Politician: https://tryglasshouse.ai/politicians/T000490.md
- Record: https://tryglasshouse.ai/trades/2990c0e8-5c57-4cc6-84ff-17e75b17f2c3.md

## 2. David Taylor

- Member: Republican, House
- Transaction: Sell, $1,001 - $15,000
- Dates: traded Jan 29, 2026, disclosed Feb 2, 2026
- Market context: $475.68 at trade, $508.34 current (+6.87%)
- Politician: https://tryglasshouse.ai/politicians/T000490.md
- Record: https://tryglasshouse.ai/trades/52f30319-81e0-4115-b1c9-3ac0c1674446.md

## 3. David Taylor

- Member: Republican, House
- Transaction: Buy, $1,001 - $15,000
- Dates: traded Aug 7, 2025, disclosed Sep 2, 2025
- Market context: $375.63 at trade, $508.34 current (+35.33%)
- Politician: https://tryglasshouse.ai/politicians/T000490.md
- Record: https://tryglasshouse.ai/trades/0a13d767-1f3a-495a-8b0e-e0b472779cea.md

## 4. Lisa C. McClain

- Member: Republican, House
- Transaction: Sell, $1,001 - $15,000
- Dates: traded Jun 11, 2025, disclosed Aug 13, 2025
- Market context: $452.44 at trade, $508.34 current (+12.36%)
- Politician: https://tryglasshouse.ai/politicians/M001136.md
- Record: https://tryglasshouse.ai/trades/88071096-bf39-44ce-b755-a2f2d692c604.md

## 5. Lisa C. McClain

- Member: Republican, House
- Transaction: Sell, $1,001 - $15,000
- Dates: traded Jun 10, 2025, disclosed Aug 13, 2025
- Market context: $451.52 at trade, $508.34 current (+12.58%)
- Politician: https://tryglasshouse.ai/politicians/M001136.md
- Record: https://tryglasshouse.ai/trades/63782281-adf6-4c40-8ea6-586e30634931.md

## 6. Jefferson Shreve

- Member: Republican, House
- Transaction: Sell, $15,001 - $50,000
- Dates: traded May 12, 2025, disclosed Jun 22, 2025
- Market context: $439.37 at trade, $508.34 current (+15.70%)
- Politician: https://tryglasshouse.ai/politicians/S001229.md
- Record: https://tryglasshouse.ai/trades/8fc24e8d-fcd4-4b1f-a84f-2382aa42357a.md

## 7. Byron Donalds

- Member: Republican, House
- Transaction: Sell, $1,001 - $15,000
- Dates: traded Mar 20, 2025, disclosed Apr 14, 2025
- Market context: $510.18 at trade, $508.34 current (-0.36%)
- Politician: https://tryglasshouse.ai/politicians/D000032.md
- Record: https://tryglasshouse.ai/trades/2132c0ff-c68a-45c1-9b3e-127a188ea50d.md

## 8. Byron Donalds

- Member: Republican, House
- Transaction: Sell, $1,001 - $15,000
- Dates: traded Mar 20, 2025, disclosed Apr 14, 2025
- Market context: $510.18 at trade, $508.34 current (-0.36%)
- Politician: https://tryglasshouse.ai/politicians/D000032.md
- Record: https://tryglasshouse.ai/trades/9212a623-0b4e-4f46-b117-797e2c3dacb1.md

## 9. Jefferson Shreve

- Member: Republican, House
- Transaction: Buy, $15,001 - $50,000
- Dates: traded Mar 13, 2025, disclosed Apr 11, 2025
- Market context: $502.92 at trade, $508.34 current (+1.08%)
- Politician: https://tryglasshouse.ai/politicians/S001229.md
- Record: https://tryglasshouse.ai/trades/47ef937d-859d-45f8-ae8d-7732288e917b.md

## 10. Jefferson Shreve

- Member: Republican, House
- Transaction: Buy, $15,001 - $50,000
- Dates: traded Feb 24, 2025, disclosed Mar 9, 2025
- Market context: $481.65 at trade, $508.34 current (+5.54%)
- Politician: https://tryglasshouse.ai/politicians/S001229.md
- Record: https://tryglasshouse.ai/trades/a099cffc-7314-4838-8163-98803e4e38fa.md



## About Vertex Pharmaceuticals Inc

Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases. Its key drugs are Kalydeco, Orkambi, Symdeko, and Trikafta/Kaftrio, and Alyftrek for cystic fibrosis, where Vertex therapies remain the standard of care globally. Vertex has diversified its portfolio through Casgevy, a gene-editing therapy for beta thalassemia and sickle-cell disease, and Journavx, a non-opioid pain medication approved for the treatment of moderate-to-severe acute pain in adults. Additionally, Vertex is evaluating small-molecule inhibitors of APOL1-mediated kidney diseases. Vertex is also investigating cell therapies to deliver a potential functional cure for type 1 diabetes.

Prices and percentage changes are market context, not portfolio returns. This information is not financial advice.